-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

CAR-T Cells for Mature B Cell Lympohoma and Burkitt Lymphoma

Program: Education Program
Session: Pediatric Hematological Malignancies: CARs for Kids
Hematology Disease Topics & Pathways:
Therapies, Clinically relevant
Monday, December 7, 2020, 11:25 AM-11:30 AM

Rayne H. Rouce, MD

Texas Children's Hospital, Houston, TX

Disclosures: Rouce: Tessa Therapeutics: Other, Research Funding; Novartis: Honoraria.

OffLabel Disclosure: